193 related articles for article (PubMed ID: 79522)
1. [Varying course of pancytopenia after busulfan treatment of chronic myelocytic leukemia (CML)].
Krug K; Stenzel L
Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(2):181-7. PubMed ID: 79522
[TBL] [Abstract][Full Text] [Related]
2. Treatment of busulfan-induced pancytopenia.
Stuart JJ; Crocker DL; Roberts HR
Arch Intern Med; 1976 Oct; 136(10):1181-3. PubMed ID: 1067785
[TBL] [Abstract][Full Text] [Related]
3. [High-dose busulfan with subsequent bone marrow transplantation in poor-risk forms of leukemia].
Urban C; Slavc I; Kaulfersch W; Teubl I
Wien Klin Wochenschr; 1987 Mar; 99(5):144-9. PubMed ID: 3554777
[TBL] [Abstract][Full Text] [Related]
4. Busulfan-induced sideroblastic anemia.
Fernandez LA; Zayed E
Am J Hematol; 1988 Jul; 28(3):199-200. PubMed ID: 3165601
[TBL] [Abstract][Full Text] [Related]
5. [Chronic myeloid leukemia treated with busulfan. Clinical characteristics, prognostic factors, effect of treatment and survival in 82 cases].
Larrain C; Cruz A; Codoceo V
Rev Med Chil; 1984 Sep; 112(9):898-911. PubMed ID: 6598227
[No Abstract] [Full Text] [Related]
6. Chemotherapy of chronic myelocytic leukemia.
Galton DA
Semin Hematol; 1969 Oct; 6(4):323-43. PubMed ID: 4900650
[No Abstract] [Full Text] [Related]
7. [A trial for prolongation of chronic phase of chronic myeloid leukemia--maintenance of leukocyte counts within normal range with busulfan].
Matsuo T; Tomonaga M; Kuriyama K; Jinnai I; Jubashi T; Nonaka H; Kohno T; Tsukasaki K; Atogami S; Itoyama T
Rinsho Ketsueki; 1989 May; 30(5):625-30. PubMed ID: 2795875
[TBL] [Abstract][Full Text] [Related]
8. Chronic myeloid leukaemia and a myasthenic syndrome.
Wohl MA; Wood JK
Acta Haematol; 1979; 62(4):214-8. PubMed ID: 119414
[TBL] [Abstract][Full Text] [Related]
9. Cytochemical variants of neutrophil leukocyte populations in chronic myelocytic leukaemia. A microspectrophotometric study of the change in the periodic acid-Schiff (PAS) reaction in blood and bone marrow neutrophils during busulfan treatment.
Gahrton G; Brandt L; Franzén S; Nordén A
Scand J Haematol; 1969; 6(6):365-72. PubMed ID: 4190430
[No Abstract] [Full Text] [Related]
10. [Indirubin in the treatment of chronic myelocytic leukemia (CML)--estimation of labelling index of bone marrow cells by 3H-TdR].
You YC; Mi JX; Wan JH; Yang TY; Wang ZC; Qian LS
Zhonghua Zhong Liu Za Zhi; 1987 Nov; 9(6):418-20. PubMed ID: 3482992
[TBL] [Abstract][Full Text] [Related]
11. In vitro drug sensitivity studies of CFUc in chronic myelocytic leukemia: I. Suicide indices and busulfan sensitivity determinations during the chronic phase.
Preisler HD; Kirshner J
Exp Hematol; 1983 Aug; 11(7):618-25. PubMed ID: 6576910
[TBL] [Abstract][Full Text] [Related]
12. Chromosome changes in patients treated with "Myleran".
Krajincanić B; Lazarov A; Zunić Z; Radojicić B
Strahlentherapie; 1976 May; 151(5):459-62. PubMed ID: 1064182
[TBL] [Abstract][Full Text] [Related]
13. [Toxic effects of busulfan (myleran) in the treatment of chronic myeolid leukemia].
Japp H
Schweiz Med Wochenschr; 1974 Aug; 104(32):1115-9. PubMed ID: 4548568
[No Abstract] [Full Text] [Related]
14. Chronic granulocytic leukemia: long-term remission in a patient with familial sarcoidosis.
Cheng DS; Kitahara M; Logan KH
South Med J; 1979 Jun; 72(6):645-7. PubMed ID: 287201
[TBL] [Abstract][Full Text] [Related]
15. Results of allogeneic bone marrow transplant in chronic myeloid leukaemia following conditioning with busulfan and cyclophosphamide.
Saikia TK; Advani SH; Parikh PM; Bapna A; Somjee S; Mukhopadhyay A; Gopal R; Nair CN
J Assoc Physicians India; 1999 Aug; 47(8):770-3. PubMed ID: 10778619
[TBL] [Abstract][Full Text] [Related]
16. Bullous pyoderma gangrenosum in association with myeloid leukaemia.
Cramers M
Acta Derm Venereol; 1976; 56(4):311-2. PubMed ID: 60030
[TBL] [Abstract][Full Text] [Related]
17. Treatment of chronic myeloid leukemia with repeated single doses of busulfan.
Sullivan JR; Hurley TH; Bolton JH
Cancer Treat Rep; 1977; 61(1):43-5. PubMed ID: 266418
[TBL] [Abstract][Full Text] [Related]
18. [Pulmonary fibrosis after busulfan therapy].
Jandl H; Franke A; Albrecht G
Z Gesamte Inn Med; 1975 Dec; 30(24):799-801. PubMed ID: 1062873
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis and proliferation (PCNA labelling) in CML--a comparative immunohistological study on bone marrow biopsies following interferon and busulfan therapy.
Thiele J; Zirbes TK; Lorenzen J; Kvasnicka HM; Dresbach S; Manich B; Leder LD; Niederle N; Diehl V; Fischer R
J Pathol; 1997 Mar; 181(3):316-22. PubMed ID: 9155719
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic bone marrow transplantation in high-risk myeloid disorders using busulfan, cytosine arabinoside and cyclophosphamide (BAC).
Ratanatharathorn V; Karanes C; Lum LG; Uberti J; Dan ME; de Planque MM; Schultz KR; Cronin S; Leisz MC; Mohamed A
Bone Marrow Transplant; 1992 Jan; 9(1):49-55. PubMed ID: 1543949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
